Methodology Development
The project team developed a microbial risk assessment framework that is consistent with the epidemiology of infectious disease transmission and the general approach recommended by U.S. EPA. The method has two components: an exposure assessment and a health effects assessment. The exposure assessment component quantifies the amount of pathogens to which individuals or populations are exposed (the dose). The dose is then input into the health effects component, which quantifies the associated health risks using a model that incorporates properties unique to infectious diseases, including person-to-person transmission and immunity (see Figure 1 ). The project team applied this framework to pathogens in landapplied biosolids. First, they identified the factors that influence pathogen exposure and transmission rates. For exposure, factors include application rate of biosolids, concentration of pathogens in biosolids, additional sources of pathogens in soil, and pathogens' die-off or growth rate in soil.
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Transmission factors include rate of person-to-person transmission, immunity in the population, percentage of carriers who are unaware that they are carrying the disease, and the disease's incubation period. The project team's model incorporates all of these factors and accounts for the interdependency of some of them.
The final model provides an estimate of attributable risk -the number of cases of an illness in a population associated with a particular exposure (in this case, exposure to biosolids).
Methodology Demonstration and Risk Characterization
The model identifies the data needed to estimate health risks from pathogens in biosolids. The project team's next step was to collect that data and demonstrate their model using a case study.
The team chose to use enteroviruses as a model pathogen, and conducted a literature review to find the necessary data. They also chose to focus on the simplest route of pathogen exposuredirect ingestion of biosolids-amended soil. Other routes of exposure to pathogens from land-applied biosolids could include surface water ingestion, groundwater ingestion, plant ingestion, and inhalation. Although the team chose to focus on only one route, their model is applicable for all of these routes if the data is sufficient.
The team used the model to map out high-risk and low-risk conditions for biosolids-based pathogen exposure. They found four important factors that strongly influenced the risk level: 1) Ratio of exposure due to biosolids, as compared with exposure due to other environmental factors; 2) rate of infectious individuals shedding pathogens into the environment; 3) rate of person-to-person transmission; and 4) duration of immunity. The project team found that the risk of disease due to biosolids is low when 1) pathogen exposure from biosolids is small compared to exposure from other sources, 2) pathogen-shedding rate is either high or low (but not medium), and 3) secondary transmission rate is relatively high.
Conclusions and Recommendations
This project developed and demonstrated a risk-based methodology for assessing the risk to human health from exposure to pathogens via biosolids. The methodology will be useful at both the regulatory and operational levels -regulators will be able to use it to review and revise pathogen regulations in the Part 503 rule, and operators will be able to use it to quantify differences in the potential health impacts of various biosolids treatment processes.
However, further research is needed to test the model with scenarios that are more realistic than the simplified case study used in this research. WERF has begun work on a second phase of the project, which will use the model to characterize the risk associated with real world biosolids application scenarios.
